Invesaro

Stocks Real estate SBRA

NASDAQ · Real estate

Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT, Inc. brought in $919.1M of revenue over the twelve months to September 30, 2026, up 23.4% from a year earlier. Net income was $71.5M, a net margin of 7.8%. At September 30, 2026 it held $36.2M in cash against $2.4B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 2, 2026.

Free, no password. An email when SBRA files with the SEC.

Price
$21.41
-0.28% on the day · November 10, 2026
52-week range $17.54 to $22.77
Market cap
$5.5B
Revenue (last 12 months)
$919.1M
+23.4% year on year
Net margin
7.8%
P/E
33.5
on FY2025 diluted EPS

Key facts about Sabra Health Care REIT, Inc.

Net worth
Sabra Health Care REIT, Inc. has a market value (market cap) of $5.5B at the latest share price, and shareholders' equity of $2.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $774.6M (+10.2% year on year), with net income of $155.6M. Over the 12 months to September 30, 2026: revenue $919.1M, net income $71.5M.
Cash flow
In fiscal 2025 operations brought in $348.6M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 2, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Sabra Health Care REIT, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Sabra Health Care REIT, Inc. declared dividends of $1.20 per share in fiscal 2025, a yield of 5.60% at the current price.

What Sabra Health Care REIT, Inc. does

Sabra Health Care REIT, Inc. is registered with the SEC under industry code SIC 6798 (Real Estate Investment Trusts). Its shares trade on NASDAQ under the ticker SBRA.

Revenue and profit by year

Revenue
FY18: $623.4M $623.4M FY18FY19: $661.7M $661.7M FY19FY20: $598.6M $598.6M FY20FY21: $569.5M $569.5M FY21FY22: $624.8M $624.8M FY22FY23: $647.5M $647.5M FY23FY24: $703.2M $703.2M FY24FY25: $774.6M $774.6M FY25
Net income
FY18: $279.1M $279.1M FY18FY19: $69M $69M FY19FY20: $138.4M $138.4M FY20FY21: -$113.3M -$113.3M FY21FY22: -$77.6M -$77.6M FY22FY23: $13.8M $13.8M FY23FY24: $126.7M $126.7M FY24FY25: $155.6M $155.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$774.6Mn/a$155.6M$0.64n/a
2024$703.2Mn/a$126.7M$0.54n/a
2023$647.5Mn/a$13.8M$0.06n/a
2022$624.8Mn/a-$77.6M-$0.34n/a
2021$569.5Mn/a-$113.3M-$0.52n/a
2020$598.6Mn/a$138.4M$0.67n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 11, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 12, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SBRA ranks in Real estate

Revenue$774.6M
#82 of 232 in Real estate · Top 35%
Revenue growth+10.2%
#51 of 207 in Real estate · Top 24%
Net margin20.1%
#67 of 210 in Real estate · Top 32%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Real estate

Dividends

Sabra Health Care REIT, Inc. declared $1.20 per share in fiscal 2025. At the current price that is a yield of 5.60%. It paid out $289.5M in cash dividends, 186% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$1.20$289.5M186%
2024$1.20$280.2M221%
2023$1.20$277.4M2,017%
2022$1.20$277.2Mn/a
2021$1.20$262.9Mn/a
2020$1.35$278.3M201%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Sabra Health Care REIT, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 2, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 31% to $249.6M versus the same quarter last year; diluted EPS $0.11 versus $0.09.
  2. November 2, 2026
  3. August 3, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 25% to $235.9M versus the same quarter last year; diluted EPS -$0.10 versus $0.27.
  4. August 3, 2026
  5. July 21, 2026
  6. June 17, 2026
  7. May 28, 2026
  8. April 30, 2026
  9. April 29, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 21% to $221.8M versus the same quarter last year; diluted EPS $0.16 versus $0.17.
  10. April 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 9, 2026. Insider transactions on SEC

Insider trades

What the people running Sabra Health Care REIT, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $4.2M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$4.2M
last 90 days
Net sold
200,000
$4.2M
DateInsiderWhatSharesPriceValueFiling
September 8, 2026 Matros Richard KChair, CEO and President, Director Soldpre-planned (10b5-1), indirect 200,000 $20.83 $4.2M Form 4
August 31, 2026 Foster Michael JDirector Received as pay 791 - - Form 4
August 31, 2026 Matros Richard KChair, CEO and President, Director Received as pay 13,867 - - Form 4
August 31, 2026 Barbarosh Craig A.Director Received as pay 791 - - Form 4
August 31, 2026 Malehorn Jeffrey A.Director Received as pay 791 - - Form 4
August 31, 2026 Katzmann Lynne SDirector Received as pay 791 - - Form 4
August 31, 2026 Kono AnnDirector Received as pay 791 - - Form 4
August 31, 2026 Costa Michael LourencoExecutive VP, CFO & Treasurer Received as pay 4,158 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SBRA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Portfolio Management13G, passive 9.21% 23,239,071 April 29, 2026
Principal Real Estate Investors LLC13G, passive with 1 related filers 8.6% 21,331,583 February 6, 2026
Vanguard Capital Management13G, passive 5.28% 13,315,431 April 30, 2026

Latest filings below 5%: The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 463 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.41,614,351$811.9M+2,515,962
Principal Financial Group Inc24,706,070$482M-346,051
Vanguard Portfolio Management LLC23,352,373$455.6M+209,125
State Street Corp12,305,655$240.1M+205,704
Vanguard Capital Management LLC11,349,125$221.4M+118,377
Geode Capital Management, LLC7,909,172$154.3M+458,403
Centersquare Investment Management LLC5,814,427$113.4M+1,936,617
Bank of America Corp5,300,762$103.4M-108,399
Charles Schwab Investment Management Inc4,840,401$94.4M+67,098
Nuveen, LLC4,464,764$87.1M-2,208,520
Lasalle Investment Management Securities LLC4,278,884$83.5M+454,262
Rush Island Management, LP4,210,530$82.1M+2,612,243
Northern Trust Corp3,855,404$75.2M+32,232
Dimensional Fund Advisors LP3,659,815$71.4M-65,522
Goldman Sachs Group Inc3,439,531$67.1M-294,410
Sumitomo Mitsui Trust Group, Inc.3,439,381$67.1M+230,781
Duff & Phelps Investment Management Co3,331,616$65M+503,171
Norges Bank3,313,984$64.7Mnew
Jpmorgan Chase & Co3,231,743$63.3M-4,969,477
Bank of New York Mellon Corp3,239,486$63.2M-61,653

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

11 insiders reported holding 4,106,870 shares in total, about $87.9M at the last price.

HolderSharesAs of
Matros Richard KChair, CEO and President, Director 2,613,9541,657,686 held indirectly September 8, 2026
Costa Michael LourencoExecutive VP, CFO & Treasurer 469,879 August 31, 2026
Nevo-Hacohen TalyaExecutive VP, CIO & Treasurer 340,355 November 28, 2025
Malehorn Jeffrey A.Director 117,137 August 31, 2026
Smith DarrinExecutive VP, CIO & Secretary 116,919 August 31, 2026
Katzmann Lynne SDirector 86,912 August 31, 2026
Cusack CatherineDirector 82,847 August 31, 2026
Foster Michael JDirector 82,834 August 31, 2026
Flores JessicaExecutive VP & CAO 72,476 August 31, 2026
Kono AnnDirector 68,977 August 31, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SBRA

What does Sabra Health Care REIT, Inc. do?

Sabra Health Care REIT, Inc. is a company in the Real estate sector, listed on NASDAQ as SBRA. Its shares trade on NASDAQ under the ticker SBRA.

What is Sabra Health Care REIT, Inc.'s net worth?

Sabra Health Care REIT, Inc. has a market value (market cap) of $5.5B at the latest share price, and shareholders' equity of $2.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Sabra Health Care REIT, Inc. profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $71.5M on revenue of $919.1M, a net margin of 7.8%.

How much revenue does Sabra Health Care REIT, Inc. make?

Over the twelve months to September 30, 2026 Sabra Health Care REIT, Inc. reported revenue of $919.1M. That is 23.4% more than a year earlier.

When did Sabra Health Care REIT, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 2, 2026. It covers the period to September 30, 2026.

When is Sabra Health Care REIT, Inc.'s next earnings report?

Sabra Health Care REIT, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does Sabra Health Care REIT, Inc. pay a dividend?

Yes. Sabra Health Care REIT, Inc. declared dividends of $1.20 per share in fiscal 2025, a yield of 5.60% at the current price.

Similar companies

Compare SBRA with

Compare SBRA with any company

Follow SBRA

Get an email when Sabra Health Care REIT, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SBRA files with the SEC.

Where the numbers come from

Financial figures are the values Sabra Health Care REIT, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.